Oxipit highlights study on ChestLink application

By AuntMinnieEurope.com staff writers

May 28, 2022 -- Oxipit is promoting the results of a study that shows its autonomous artificial intelligence (AI) application ChestLink misses no critical findings. The preprint of the study was released on May 25.

Researchers at Oulu University Hospital found that the ChestLink software identified normal studies with 99.8% sensitivity and specificity of 36.4%, with a "minimal" number of false negatives and no critical findings missed. The application analyzed 10,000 chest x-rays of Finnish primary healthcare patients.

Researchers wrote that using AI to rule out normal studies could optimize the use of resources in healthcare, such as radiology workforces.


Copyright © 2022 AuntMinnieEurope.com
 

To read this and get access to all of the exclusive content on AuntMinnieEurope.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnieEurope.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: